Get Adobe Flash player

Benjamin Reubinoff M.D. PhD

Prof. Benjamin ReubinoffA brief biographical sketch

Chairman
The Department of Obstetrics and Gynecology
Hadassah University Medical Center, Jerusalem, Israel.

Director
The Sidney and Judy Swartz Embryonic Stem Cell Research Center of
The Goldyne Savad Institute of Gene Therapy & The Department of Obstetrics and Gynecology
Hadassah University Medical Center, Jerusalem, Israel.



Prof. Reubinoff received his M.D. degree from the Hebrew University - Hadassah Medical School, Jerusalem, Israel. He completed his residency in Obstetrics and Gynecology at the Hadassah Medical Center. Prof Reubinoff also holds a PhD degree in developmental biology from Monash University, Melbourne, Australia.

Currently, Prof. Reubinoff is a full Professor of Obstetrics and Gynecology and serves as Chairman of the Department of Obstetrics and Gynecology. He is also the director of the Hadassah Human Embryonic Stem Cell Research Center.

The major focus of Prof. Reubinoff’s research has been human embryonic stem cells (hESCs). Professor Reubinoff derived in collaboration with scientists from Monash University in Melbourne and the National University of Singapore, ES cell lines from human embryos. The group was the second in the world to derive human embryonic stem cell (hESC) lines and the first to show somatic differentiation of the hESCs in culture.

Prof. Reubinoff established the Sidney and Judy Swartz Embryonic Stem Cell Research Center, which he directs. The major focus of the Center is the development of the technology that may eventually allow the exploitation of hESCs for regenerative medicine. Current areas of research include the development of hESC lines that will be eligible for future clinical transplantation use, the development of hESC-derived progeny for the treatment of neural and retinal degenerative disorders.
Other areas of interest include the derivation of new hESC lines from abnormal pre-implantation genetically diagnosed (PGD) embryos and the development of induced pluripotent stem (iPS) cells as models of human diseases, genetic modifications of hESCs, characterizing the immunogenicity of hESCs and the study of aspects related to somatic cell nuclear transfer (SCNT) and reprogramming.

Prof. Reubinoff was awarded with many prizes for his work in the area of hESCs and has published multiple papers and authored multiple chapters on this topic.

Organizer & Producer:

bioforum-newlogo Tel:08-9313070
Fax:08-9313071